Item 1.02 Termination of a Material Definitive Agreement.
BRRX Clinical Joint Venture Termination
On June 15, 2020 the Company entered into a settlement agreement with Bareroots RX, Inc., terminating the joint venture called BRRX Clinical, Inc. As a condition of the termination, which expressly incorporates no admission of liability, the Company received $95,689 and the return of all the stock issued (2,000,000 shares of MCIG common stock) as a part of the settlement.